32-34 NEW PHARMA - In therapies PharmaTimes March explores today's life sciences landscape: patient autonomy where access to medicines is expected. Shifting politics, "super employees," ongoing innovation, GLP-1s, difficult-to-treat...

#obesity #diabetes #typeIIdiabetes #oncology #neurology #rarediseases #womenshealth #EliLilly #Akeso #SummitTherapeutics #precisionmedicine #immunotherapy #Alzheimersdisease #AstraZeneca #DaiichiSankyo #ADCs #precisiononcology #DrugstoWatch2026 #immunology #cardiology #CGTs
zurl.co/c8PJw

Daiichi Sankyo gears up for five ADC launches in 2026

#DaiichiSankyo #ADCs #ADClaunches #Enhertu #Datroway #breastcancer #Oncology #antibodydrugconjugates #trastuzumabderuxtecan #datopotamabderuxtecan #pertuzumab #earlystagebreastcancer #triplenegativebreastcancer #Ifinatamabderuxtecan #IDXd #TROPIONBreast05study #ADCtechnology
zurl.co/TySHW

Ex-Novartis CMO John Tsai joins Daiichi Sankyo Daiichi Sankyo has named John Tsai as its new chief medical officer, replacing Ken Takeshita, who is stepping down after five years in the role.

#DaiichiSankyo has named #JohnTsai as its new chief medical officer (#CMO), replacing Ken Takeshita, who is stepping down after five years in the role on 1st April.

pharmaphorum.com/news/ex-nova...

Daiichi Sankyo Healthcare Hosts Skin Care Seminar for Young Adult Cancer Patients A seminar hosted by Daiichi Sankyo Healthcare aims to enhance the quality of life for young adult women battling cancer through effective skin care.

Daiichi Sankyo Healthcare Hosts Skin Care Seminar for Young Adult Cancer Patients #Japan #Skincare #Tokyo #AYA #DaiichiSankyo

EU starts review of first-line Enhertu for breast cancer EMA starts its review of first-line Enhertu in HER2+ breast cancer, which could dramatically increase the eligible patient population for the drug.

The #EMA has started its review of #DaiichiSankyo and #AstraZeneca's #Enhertu as a first-line therapy for #HER2positive #breastcancer, setting up a possible approval later this year.

Datroway filed for TNBC in EU after data delay Daiichi Sankyo and AstraZeneca have moved swiftly to file for approval of TROP2-targeting Datroway for triple-negative breast cancer.

#DaiichiSankyo and #AstraZeneca have pressed swiftly to file for approval of their #TROP2-targeting drug Datroway for triple-negative #breastcancer (TNBC) in the #EU, shortly after reporting positive #survivaldata in a pivotal trial.

Enhertu moves into frontline breast cancer treatment Daiichi Sankyo and AstraZeneca's Enhertu has become the first new first-line option in the US for HER2-positive breast cancer in more than a decade

#DaiichiSankyo and #AstraZeneca's Enhertu has become the first new first-line option in the US for HER2-positive breast cancer in more than a decade.

pharmaphorum.com/news/enhertu...

A US #appealscourt has reversed a 2023 decision that ordered #DaiichiSankyo to pay royalties on sales of its antibody-drug conjugate (#ADC) Enhertu to #Seagen, now part of #Pfizer.

buff.ly/AWM9US3

34-35 PHARMA - Time capsule Time capsule. The ten groundbreaking drugs shaping 2025 and the future

#Vertex #Cysticfibrosis #AstraZeneca #DaiichiSankyo #lungcancer #breastcancer #painmanagement #Alnylam #Sanofi #Haemophilia #Genentech #Roche #MS #MSD #Hypercholesterolemia #Pfizer #InnoventBiologics #EliLilly #Obesity #type2diabetes #GSK #eosinophilicasthma #meningitisvaccine
zurl.co/bzBzK

Delayed TNBC readout for Datroway delivers survival benefit AstraZeneca and Daiichi Sankyo's Datroway comes good in the delayed TROPION-Breast02 trial as a frontline triple-negative breast cancer treatment.

#breastcancer #triplenegativebreastcancer #TNBC #AstraZeneca #AZ #Datroway #datopotamabderuxtecan #DaiichiSankyo #Oncology #TNBCpatients #TROPIONBreast02trial #metastaticTNBC #immunotherapy #TNBCtumours #Gilead #TROP2ADC #Trodelvy #sacituzumabgovitecan #PFSdata
zurl.co/t8A6T

#AstraZeneca and #DaiichiSankyo pushed back the readout of their trial of Datroway in triple-negative #breastcancer (TNBC) patients ineligible for frontline immunotherapies, but the result has been worth the wait.

pharmaphorum.com/news/delayed...

Forums | CancerGRACE

📌 Más recursos: cancergrace.org/forum
Agradecemos a nuestros patrocinadores por hacerlo posible: #janssen #takeda #genentech #bms #daiichisankyo

Introducing Minon Wash-Free Medicinal Hair Shampoo for Kids by Daiichi Sankyo Healthcare Daiichi Sankyo Healthcare has launched a new medicated hair shampoo for children, designed for sensitive skin. This unique no-rinse formula is perfect for kids!

Introducing Minon Wash-Free Medicinal Hair Shampoo for Kids by Daiichi Sankyo Healthcare #Japan #Tokyo #MINON #DaiichiSankyo #KidsShampoo

NEWS: #Gilead lays down a marker for #AZ and #DaiichiSankyo to follow as Trodelvy scores in first-line treatment of triple-negative breast cancer at #ASCO25.

pharmaphorum.com/news/asco-25...

Enhertu poised to move first line in HER2+ breast cancer New data could make HER2-directed antibody-drug conjugate (ADC) Enhertu an option for previously untreated breast cancer for the first time.

News Catch-Up: Yesterday, #AstraZeneca and #DaiichiSankyo announced preparation of #regulatory filings that could make their #HER2-directed antibody-drug conjugate (#ADC) #Enhertu an option for previously untreated #breastcancer for the first time.

FDA Greenlights AstraZeneca and Daiichi Sankyo’s Datroway for Breast Cancer Treatment AstraZeneca and Daiichi Sankyo have scored a significant win with the U.S.

www.linkedin.com/pulse/fda-gr...

FDA Greenlights AstraZeneca and Daiichi Sankyo’s Datroway for Breast Cancer Treatment

kstrategyand.com/pharma-news

#AstraZeneca #DaiichiSankyo #HealthcareInnovation #ADCTherapy #TargetedTherapies #MedicalBreakthrough #CancerCare #Humanteconomy #Humantec

This ON-DEMAND video of this event is available now here: youtu.be/_9k0wA47XUI

We would love your feedback - please fill out our questionnaire after you have watched the video!
docs.google.com/forms/d/e/1F...

A huge thank you to our sponsors! #astrazeneca #daiichisankyo #regeneron #takedaoncology

Lung Cancer OncTalk - It's a Wrap! Thank you for attending the December 2024 Lung Cancer OncTalk. We are pleased that you were able to join us. Whether you attended LIVE ONLINE or have viewed the event ON DEMAND, we hope the event an...

We would love your feedback - please fill out our questionnaire after you have watched the video!
docs.google.com/forms/d/e/1F...

A huge thank you to our sponsors! #astrazeneca #daiichisankyo #regeneron #takedaoncology

Click here to watch the full video: youtu.be/_9k0wA47XUI

LGBT+: farmacêutica Japonesa abre vagas para estagiários! “Na Daiichi Sankyo, o Programa de Estágio é uma iniciativa que ultrapassa o convencional, representando mais que uma oportunidade profission...

LGBT+: farmacêutica Japonesa abre vagas para estagiários! #lgbt #japão #farmacêutica #daiichisankyo #estagio - cinearcoirisolivro.blogspot.com/2024/12/lgbt...

Plan social #DaiichiSankyo: grève de la faim des élus, l’#UNSA demande au Premier Ministre @BCazeneuve d'intervenir.

bit.ly/2hCw5fP